 6. Patients can be naïve to biologic therapy or have had exposure to TNF or biologic therapy see appropriate wash out schedule and be experiencing at least a moderate disease activity score as determined by a CDAI of 10 at Screening despite currently receiving Methotrexate therapy at a dose of 10-25 mgweekly for at least 12 weeks and at a stable dose for the past 4 weeks. 